Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valérie Jullian
Simalikalactone E (SkE), a New Weapon in the Armamentarium of Drugs Targeting Cancers That Exhibit Constitutive Activation of the ERK Pathway
Oncotarget
Oncology
Related publications
Activation of the Hedgehog Pathway in Gastroesophageal Cancers
Journal of Solid Tumors
Cancer Research
Oncology
Radiology
Nuclear Medicine
Imaging
Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers
Oncogene
Cancer Research
Genetics
Molecular Biology
Baicalein Inhibits Melanogenesis Through Activation of the ERK Signaling Pathway
International Journal of Molecular Medicine
Medicine
Genetics
OC-069 Constitutive Activation of the DNA Damage Response Pathway in Cancer Represents a Deregulated Pathway
Gut
Gastroenterology
Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)
Oncology Letters
Cancer Research
Oncology
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine
Molecular Cancer Therapeutics
Cancer Research
Oncology
Activation of the MEK–S6 Pathway in High-Grade Ovarian Cancers
Applied Immunohistochemistry and Molecular Morphology
Forensic Medicine
Pathology
Medical Laboratory Technology
Histology
Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Targeting the ERK Pathway Reduces Liver Metastasis of Smad4-Inactivated Colorectal Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology